Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Caffeic acid is a phenolic compound with notable antioxidant properties, often used in the synthesis of hybrid molecules to enhance bioactivity. It has been incorporated into flavonoid derivatives like quercetin-caffeic acid conjugates to improve antioxidative effects for potential applications in preventing age-related macular degeneration (AMD). Additionally, caffeic acid has been combined with lipoic acid in phenol-lipoyl hybrids, demonstrating neuroprotective and antioxidant effects in anti-Alzheimer research, highlighting its versatility in medicinal chemistry.

331-39-5

Post Buying Request

331-39-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

331-39-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 331-39-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,3 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 331-39:
(5*3)+(4*3)+(3*1)+(2*3)+(1*9)=45
45 % 10 = 5
So 331-39-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/p-1/b4-2+

331-39-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0002)  Caffeic Acid  >98.0%(T)

  • 331-39-5

  • 5g

  • 235.00CNY

  • Detail
  • TCI America

  • (C0002)  Caffeic Acid  >98.0%(T)

  • 331-39-5

  • 25g

  • 780.00CNY

  • Detail
  • Alfa Aesar

  • (A15950)  3,4-Dihydroxycinnamic acid, predominantly trans, 98+%   

  • 331-39-5

  • 10g

  • 546.0CNY

  • Detail
  • Alfa Aesar

  • (A15950)  3,4-Dihydroxycinnamic acid, predominantly trans, 98+%   

  • 331-39-5

  • 50g

  • 2084.0CNY

  • Detail
  • Sigma-Aldrich

  • (60018)  Caffeicacid  matrix substance for MALDI-MS, ≥99.0% (HPLC)

  • 331-39-5

  • 60018-1G

  • 973.44CNY

  • Detail
  • Sigma-Aldrich

  • (60018)  Caffeicacid  matrix substance for MALDI-MS, ≥99.0% (HPLC)

  • 331-39-5

  • 60018-5G

  • 3,846.96CNY

  • Detail
  • USP

  • (1084995)  Caffeicacid  United States Pharmacopeia (USP) Reference Standard

  • 331-39-5

  • 1084995-15MG

  • 4,647.24CNY

  • Detail
  • Sigma

  • (C0625)  Caffeicacid  ≥98.0% (HPLC)

  • 331-39-5

  • C0625-2G

  • 499.59CNY

  • Detail
  • Sigma

  • (C0625)  Caffeicacid  ≥98.0% (HPLC)

  • 331-39-5

  • C0625-5G

  • 752.31CNY

  • Detail
  • Sigma

  • (C0625)  Caffeicacid  ≥98.0% (HPLC)

  • 331-39-5

  • C0625-25G

  • 1,749.15CNY

  • Detail

331-39-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name cis-caffeic acid

1.2 Other means of identification

Product number -
Other names CAFFIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:331-39-5 SDS

331-39-5Synthetic route

malonic acid
141-82-2

malonic acid

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With silica gel at 110 - 120℃; for 0.0833333h; Condensation; Solid-phase reaction; Decarboxylation; microwave irradiation;76%
With pyridine; aniline In toluene at 95℃;55.7%
With pyridine; aniline In toluene for 2h; Reflux;44.2%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With sodium dihydrogenphosphate at 25℃; for 0.25h; pH=7; Reagent/catalyst; Glovebox;50%
With dipotassium hydrogenphosphate; iron(II) sulfate; citric acid at 30℃; for 1h; Product distribution; pH 5.0, investigated effects of various metal ions and various compounds and enzymes;
With leaves Silene dioica at 30℃; for 0.166667h; Mechanism; incubation with glucose-6-posphate and NADP;
methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate
40918-96-5

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
Stage #1: methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate With boron tribromide In chloroform at 25℃; for 16h;
Stage #2: With sodium hydrogencarbonate In chloroform; water at 25℃; pH=7;
38.3%
(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid
1135-24-6

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With oxygen; copper(II) perchlorate; ascorbic acid In water24%
In various solvent(s) at 37℃; for 1h; Product distribution; Mechanism; air, phenobarbital-induced rat liver microsomes NADPH, pH = 7.4; other enzymatic system;
(E)-3-phenylacrylic acid
140-10-3

(E)-3-phenylacrylic acid

A

1-[3-(4-hydroxyphenyl)-2-propenoate]-β-D-glucopyranoside
13080-39-2

1-[3-(4-hydroxyphenyl)-2-propenoate]-β-D-glucopyranoside

B

caffeic acid
331-39-5

caffeic acid

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
In ethanol; water at 25℃; for 72h; cell culture of Nicotiana tabacum;
Conditions
ConditionsYield
at 30℃; for 0.5h; pH 6.4; enzyme from Ipomoea batatas;
3-(3',4'-dioxo-1',5'-cyclohexadienyl)propenoic acid
92279-06-6

3-(3',4'-dioxo-1',5'-cyclohexadienyl)propenoic acid

sodium benzenesulfonate
873-55-2

sodium benzenesulfonate

A

caffeic acid
331-39-5

caffeic acid

B

6'-phenysulfonylcaffeic acid
58058-71-2

6'-phenysulfonylcaffeic acid

C

5'-phenysulfonylcaffeic acid
58058-69-8

5'-phenysulfonylcaffeic acid

Conditions
ConditionsYield
With O at 30℃; for 48h; alkaline solution, pH 10.0;
3-caffeoylquinic acid
202650-88-2

3-caffeoylquinic acid

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With hydrogenchloride; ethanol for 4h; Heating;
calceolarioside B
106972-94-5, 105471-98-5

calceolarioside B

A

D-Glucose
2280-44-6

D-Glucose

B

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 90℃; for 2h; Product distribution; study of the acid hydrolysis;
3,4-dihydroxy-β-phenethyl-O-β-D-glucopyranosyl-(1->3)-4-O-caffeoyl-β-D-glucopyranoside
104777-68-6

3,4-dihydroxy-β-phenethyl-O-β-D-glucopyranosyl-(1->3)-4-O-caffeoyl-β-D-glucopyranoside

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With sodium hydroxide at 50℃; for 1h; Product distribution;
cis-verbascoside
97747-56-3

cis-verbascoside

A

D-Glucose
2280-44-6

D-Glucose

B

L-rhamnose
73-34-7

L-rhamnose

C

caffeic acid
331-39-5

caffeic acid

D

hydroxytyrosol
10597-60-1

hydroxytyrosol

Conditions
ConditionsYield
With hydrogenchloride; potassium hydroxide 1.) MeOH, H2O, reflux, 3 h; 2.) MeOH, H2O, reflux;
methyl 2,5-di-O-caffeyl-α-L-arabinofuranoside
110065-28-6

methyl 2,5-di-O-caffeyl-α-L-arabinofuranoside

A

caffeic acid
331-39-5

caffeic acid

B

methyl β-L-arabinofuranoside
3795-69-5

methyl β-L-arabinofuranoside

Conditions
ConditionsYield
With sodium hydroxide In methanol Product distribution;

A

caffeic acid
331-39-5

caffeic acid

B

deacaffeoylacetoside

deacaffeoylacetoside

Conditions
ConditionsYield
With sodium hydroxide In methanol for 4h; Ambient temperature;A 51 mg
B 195 mg

A

caffeic acid
331-39-5

caffeic acid

B

D-(-)-quinic acid
77-95-2

D-(-)-quinic acid

Conditions
ConditionsYield
With water; unspecific esterase hydrolysis;
With water hydrolysis with unspecific esterase;
ladroside
76994-10-0

ladroside

A

caffeic acid
331-39-5

caffeic acid

B

mussaenoside
64421-27-8

mussaenoside

Conditions
ConditionsYield
With sodium hydroxide In methanol Ambient temperature;
6-O-(trans-caffeoyl)-D-glucopyranose

6-O-(trans-caffeoyl)-D-glucopyranose

A

D-Glucose
2280-44-6

D-Glucose

B

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol Heating;
5-trans-caffeoylshikimic acid
73263-62-4

5-trans-caffeoylshikimic acid

A

caffeic acid
331-39-5

caffeic acid

B

shikimic acid
138-59-0

shikimic acid

Conditions
ConditionsYield
In hydrogenchloride reflux 30 min, room temp. overnight;
1,6-di-O-caffeoyl-D-glucopyranoside
23284-22-2, 29048-92-8, 56614-74-5

1,6-di-O-caffeoyl-D-glucopyranoside

A

D-Glucose
2280-44-6

D-Glucose

B

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol Heating;
ainsliaside A
93236-48-7

ainsliaside A

A

caffeic acid
331-39-5

caffeic acid

B

glucozaluzanin C
57576-33-7

glucozaluzanin C

Conditions
ConditionsYield
With sodium hydroxide In water for 1h; Ambient temperature;
forsythiaside
79916-77-1

forsythiaside

A

D-Glucose
2280-44-6

D-Glucose

B

L-rhamnose
73-34-7

L-rhamnose

C

caffeic acid
331-39-5

caffeic acid

D

hydroxytyrosol
10597-60-1

hydroxytyrosol

Conditions
ConditionsYield
With hydrogenchloride; sodium hydroxide Ambient temperature; hydrolysis;
(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate
122412-14-0

(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

A

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
In water for 2h; Ambient temperature; tannase;
rossicaside A
112664-03-6

rossicaside A

A

caffeic acid
331-39-5

caffeic acid

B

hydroxytyrosol
10597-60-1

hydroxytyrosol

Conditions
ConditionsYield
With hesperidinase In water at 32℃; for 48h; Product distribution;
1″-O-7-(4-hydroxyphenyl)-7-ethyl-6″-[(8E)-7-(3,4-dihydroxyphenyl)-8-propenoate]-β-D-glucopyranoside

1″-O-7-(4-hydroxyphenyl)-7-ethyl-6″-[(8E)-7-(3,4-dihydroxyphenyl)-8-propenoate]-β-D-glucopyranoside

A

D-Glucose
2280-44-6

D-Glucose

B

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 90℃; for 2h; Product distribution; study of the acid hydrolysis;
(E)-caffeoyl-(E)-feruloylspermidine

(E)-caffeoyl-(E)-feruloylspermidine

A

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid
1135-24-6

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid

B

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With sodium hydroxide at 100℃; for 4h; Title compound not separated from byproducts;
3,4-dihydroxy-β-phenethyl-O-β-D-glucopyranosyl-(1->3)-O-α-rhamnopyranosyl-(1->6)-4-caffeoyl-β-D-glucopyranoside

3,4-dihydroxy-β-phenethyl-O-β-D-glucopyranosyl-(1->3)-O-α-rhamnopyranosyl-(1->6)-4-caffeoyl-β-D-glucopyranoside

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With sodium hydroxide at 50℃; for 1h; Product distribution;
querspicatin A

querspicatin A

A

caffeic acid
331-39-5

caffeic acid

B

querspicatin B

querspicatin B

Conditions
ConditionsYield
With potassium hydroxide for 8.5h; Heating;A n/a
B 20 mg
N1,N5-di-p-coumaroyl-N10-caffeoylspermidine

N1,N5-di-p-coumaroyl-N10-caffeoylspermidine

A

caffeic acid
331-39-5

caffeic acid

B

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium hydroxide; sodium tetrahydroborate In water at 100℃; for 4h; Product distribution;
N1-p-coumaroyl-N5,N10-dicaffeoylspermidine

N1-p-coumaroyl-N5,N10-dicaffeoylspermidine

A

caffeic acid
331-39-5

caffeic acid

B

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium hydroxide; sodium tetrahydroborate In water at 100℃; for 4h; Product distribution;
N1,N5,N10-(E)-tricaffeoylspermidine

N1,N5,N10-(E)-tricaffeoylspermidine

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With sodium hydroxide; sodium tetrahydroborate In water at 100℃; for 4h; Product distribution;
quercetin 3-<6-caffeyl-β-D-glucopyranosyl(1->2)-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside>

quercetin 3-<6-caffeyl-β-D-glucopyranosyl(1->2)-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside>

A

caffeic acid
331-39-5

caffeic acid

B

5,7-dihydroxy-3-[β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl]-2-(3,4-dihydroxyphenyl)-4H-1-benzopyran-4-one
38681-85-5

5,7-dihydroxy-3-[β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl]-2-(3,4-dihydroxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sodium hydroxide In sodium hydroxide for 24h; Product distribution; Ambient temperature; other reagent;
methanol
67-56-1

methanol

caffeic acid
331-39-5

caffeic acid

Methyl caffeate
3843-74-1, 67667-67-8

Methyl caffeate

Conditions
ConditionsYield
With Dowex 50W-X8 Heating;100%
With sulfuric acid for 24h; Reflux;100%
With sulfuric acid at 70℃; for 1h; Inert atmosphere;100%
caffeic acid
331-39-5

caffeic acid

acetic anhydride
108-24-7

acetic anhydride

3,4-diacetoxycinnamic acid
88623-81-8

3,4-diacetoxycinnamic acid

Conditions
ConditionsYield
With pyridine at 20℃;100%
With pyridine at 20℃;95%
With pyridine at 20℃;95%
caffeic acid
331-39-5

caffeic acid

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

caffeic acid imidazolide
863107-05-5

caffeic acid imidazolide

Conditions
ConditionsYield
In tetrahydrofuran 1) room temp, 1.5 h, caution: heavy gas production, 2) reflux, 2 h;100%
In N,N-dimethyl-formamide for 2h; Ambient temperature;
ethanol
64-17-5

ethanol

caffeic acid
331-39-5

caffeic acid

Conditions
ConditionsYield
With hydrogenchloride at 70℃; for 2h;99%
With thionyl chloride for 4h; Heating;97%
With sulfuric acid In water at 82℃; for 24h; Reagent/catalyst;96%
caffeic acid
331-39-5

caffeic acid

dihydrocaffeic acid
1078-61-1

dihydrocaffeic acid

Conditions
ConditionsYield
With palladium on activated charcoal; hydrogen In methanol at 20℃; under 760.051 Torr; Inert atmosphere;99%
With palladium 10% on activated carbon; hydrogen In methanol at 25℃; under 2585.81 Torr; for 3h;95%
With ferrous ammonium sulphate hexahydrate; isopropyl β-D-thiogalactopyranoside In aq. phosphate buffer at 37℃; for 48h; Catalytic behavior; Reagent/catalyst; Concentration;92%
caffeic acid
331-39-5

caffeic acid

2-amino-phenol
95-55-6

2-amino-phenol

(E)-3-(3,4-dihydroxyphenyl)-N-(2-hydroxyphenyl)acrylamide

(E)-3-(3,4-dihydroxyphenyl)-N-(2-hydroxyphenyl)acrylamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Heating;99%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 6h; Inert atmosphere;85%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 2.5h;
With dicyclohexyl-carbodiimide In tetrahydrofuran Reflux;
caffeic acid
331-39-5

caffeic acid

3-bromoaniline
591-19-5

3-bromoaniline

(E)-N-(3-bromophenyl)-3-(3,4-dihydroxyphenyl)acrylamide

(E)-N-(3-bromophenyl)-3-(3,4-dihydroxyphenyl)acrylamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Heating;99%
HCl.H-D,L-Phe(β-OH)-OMe

HCl.H-D,L-Phe(β-OH)-OMe

caffeic acid
331-39-5

caffeic acid

caffeoyl-D,L-Phe(β-OH)-OMe

caffeoyl-D,L-Phe(β-OH)-OMe

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 4h; Cooling with ice;97.1%
2-Fluoroaniline
348-54-9

2-Fluoroaniline

caffeic acid
331-39-5

caffeic acid

(E)-3-(3,4-dihydroxyphenyl)-N-(2-fluorophenyl)acrylamide

(E)-3-(3,4-dihydroxyphenyl)-N-(2-fluorophenyl)acrylamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Heating;97%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 7h; Inert atmosphere;82%
caffeic acid
331-39-5

caffeic acid

4-chloro-aniline
106-47-8

4-chloro-aniline

(E)-N-(4-chlorophenyl)-3-(3,4-dihydroxyphenyl)acrylamide

(E)-N-(4-chlorophenyl)-3-(3,4-dihydroxyphenyl)acrylamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 6h; Heating;97%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 7h; Inert atmosphere;82%
With dicyclohexyl-carbodiimide In tetrahydrofuran Reflux;
caffeic acid
331-39-5

caffeic acid

tert-butyl 3-(piperidin-4-yl)benzylcarbamate
725228-49-9

tert-butyl 3-(piperidin-4-yl)benzylcarbamate

(E)-tert-butyl 3-(1-(3-(3,4-dihydroxyphenyl)acryloyl)piperidin-4-yl)benzylcarbamate
1290056-81-3

(E)-tert-butyl 3-(1-(3-(3,4-dihydroxyphenyl)acryloyl)piperidin-4-yl)benzylcarbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;96%
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;
caffeic acid
331-39-5

caffeic acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid
203118-32-5

(E)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid

Conditions
ConditionsYield
Stage #1: caffeic acid; tert-butyldimethylsilyl chloride With N-ethyl-N,N-diisopropylamine In dichloromethane at 25℃; for 14h;
Stage #2: With potassium carbonate In tetrahydrofuran; water for 2h;
95%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 25℃; for 14h;95%
With 1H-imidazole In N,N-dimethyl-formamide for 20h; Inert atmosphere;90%
caffeic acid
331-39-5

caffeic acid

aniline
62-53-3

aniline

(E)-3-(3,4-dihydroxyphenyl)-N-phenylacrylamide
332079-42-2

(E)-3-(3,4-dihydroxyphenyl)-N-phenylacrylamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Heating;95%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 8h; Inert atmosphere;78%
Stage #1: caffeic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 0.333333h;
Stage #2: aniline With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16.33h;
7.06%
Butane-1,4-diol
110-63-4

Butane-1,4-diol

caffeic acid
331-39-5

caffeic acid

(E)-4-hydroxybutyl 3-(3,4-dihydroxyphenyl)acrylate

(E)-4-hydroxybutyl 3-(3,4-dihydroxyphenyl)acrylate

Conditions
ConditionsYield
With sulfuric acid at 50℃; for 24h;95%
With sulfuric acid at 90℃; for 2h; Fischer–Speier Esterification; Molecular sieve;
caffeic acid
331-39-5

caffeic acid

m-Hydroxyaniline
591-27-5

m-Hydroxyaniline

(E)-3-(3,4-dihydroxyphenyl)-N-(3-hydroxyphenyl)acrylamide

(E)-3-(3,4-dihydroxyphenyl)-N-(3-hydroxyphenyl)acrylamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Heating;94%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 6h; Inert atmosphere;84%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 2.5h;
caffeic acid
331-39-5

caffeic acid

dimethyl sulfate
77-78-1

dimethyl sulfate

3,4-dimethoxy-trans-cinnamic acid
14737-89-4

3,4-dimethoxy-trans-cinnamic acid

Conditions
ConditionsYield
Stage #1: caffeic acid With sodium hydroxide In water pH=13;
Stage #2: dimethyl sulfate In water at 20℃; for 10h; pH=> 10;
Stage #3: With hydrogenchloride In water pH=2;
94%
With sodium hydroxide for 6h;78.8%
With sodium hydroxide In water for 3.5h; Heating;78.8%
silver(I) hexafluorophosphate
26042-63-7

silver(I) hexafluorophosphate

dichloro[1,4-bis(diphenylphosphino)butane](2,2'-bipyridine)ruthenium(II)
200358-34-5, 200259-33-2

dichloro[1,4-bis(diphenylphosphino)butane](2,2'-bipyridine)ruthenium(II)

caffeic acid
331-39-5

caffeic acid

C47H43N2O4P2Ru(1+)*F6P(1-)

C47H43N2O4P2Ru(1+)*F6P(1-)

Conditions
ConditionsYield
In methanol for 0.333333h; Darkness; Inert atmosphere;94%
caffeic acid
331-39-5

caffeic acid

glycerol
56-81-5

glycerol

1-monoglyceryl caffeic acid ester
123134-23-6

1-monoglyceryl caffeic acid ester

Conditions
ConditionsYield
With 1-methyl-3-(4-sulfobutyl)-1H-imidazol-3-ium 4-methylbenzene-1-sulfonate at 90℃; under 760.051 Torr; for 2h; Activation energy; Catalytic behavior; Reagent/catalyst; Temperature; Concentration;93.8%
propan-1-ol
71-23-8

propan-1-ol

caffeic acid
331-39-5

caffeic acid

n-propyl caffeate
83504-42-1, 142234-81-9

n-propyl caffeate

Conditions
ConditionsYield
With sulfuric acid under 9308.91 Torr; Microwave irradiation; Inert atmosphere; Sealed tube; Reflux;93%
Stage #1: caffeic acid With thionyl chloride In 1,4-dioxane for 1h; Heating;
Stage #2: propan-1-ol In 1,4-dioxane Heating; Further stages.;
86%
With thionyl chloride at 0 - 50℃; for 16.5h;65.2%
caffeic acid
331-39-5

caffeic acid

butan-1-ol
71-36-3

butan-1-ol

n-butyl caffeate
22020-28-6, 136944-10-0

n-butyl caffeate

Conditions
ConditionsYield
With sulfuric acid under 9308.91 Torr; Microwave irradiation; Inert atmosphere; Sealed tube; Reflux;93%
Stage #1: caffeic acid With thionyl chloride In 1,4-dioxane for 1h; Heating;
Stage #2: butan-1-ol In 1,4-dioxane Heating; Further stages.;
86%
With sulfuric acid for 0.166667h; Microwave irradiation; Heating;80%
caffeic acid
331-39-5

caffeic acid

isopropyl alcohol
67-63-0

isopropyl alcohol

(E)-isopropyl 3-(3,4-dihydroxyphenyl)acrylate

(E)-isopropyl 3-(3,4-dihydroxyphenyl)acrylate

Conditions
ConditionsYield
With sulfuric acid at 92℃; for 0.0666667h; Microwave irradiation;93%
With sulfuric acid under 9308.91 Torr; Microwave irradiation; Inert atmosphere; Sealed tube; Reflux;92%
Stage #1: caffeic acid With thionyl chloride In 1,4-dioxane for 1h; Heating;
Stage #2: isopropyl alcohol In 1,4-dioxane Heating; Further stages.;
82%
With toluene-4-sulfonic acid In benzene for 144h; Heating;23%
With toluene-4-sulfonic acid In toluene at 120℃; for 4h; Fischer esterification;
caffeic acid
331-39-5

caffeic acid

methyl chloroformate
79-22-1

methyl chloroformate

3,4-bis[(methoxycarbonyl)oxy]cinnamic acid
861897-00-9

3,4-bis[(methoxycarbonyl)oxy]cinnamic acid

Conditions
ConditionsYield
With sodium hydroxide at 0℃; for 1h;93%
With TEA In tetrahydrofuran
caffeic acid
331-39-5

caffeic acid

Propargylamine
2450-71-7

Propargylamine

(E)-3-(3,4-dihydroxyphenyl)-N-(prop-2-ynyl)acrylamide

(E)-3-(3,4-dihydroxyphenyl)-N-(prop-2-ynyl)acrylamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 27℃; for 18h;93%
Stage #1: caffeic acid; Propargylamine With benzotriazol-1-ol; triethylamine In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In N,N-dimethyl-formamide for 18h;
20%
caffeic acid
331-39-5

caffeic acid

pentafluorophenyl trifloroacetate
14533-84-7

pentafluorophenyl trifloroacetate

pentafluorophenyl 3,4-dihydroxycinnamate
916348-43-1

pentafluorophenyl 3,4-dihydroxycinnamate

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide93%
2-methyl-propan-1-ol
78-83-1

2-methyl-propan-1-ol

caffeic acid
331-39-5

caffeic acid

(E)-isobutyl 3-(3,4-dihydroxyphenyl)acrylate

(E)-isobutyl 3-(3,4-dihydroxyphenyl)acrylate

Conditions
ConditionsYield
With sulfuric acid at 118℃; for 0.0666667h; Microwave irradiation;92%
With sulfuric acid under 9308.91 Torr; Microwave irradiation; Inert atmosphere; Sealed tube; Reflux;91%
With toluene-4-sulfonic acid In toluene at 120℃; for 4h; Fischer esterification;
caffeic acid
331-39-5

caffeic acid

3-chloro-aniline
108-42-9

3-chloro-aniline

(E)-N-(3-chlorophenyl)-3-(3,4-dihydroxyphenyl)-prop-2-enamide

(E)-N-(3-chlorophenyl)-3-(3,4-dihydroxyphenyl)-prop-2-enamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Heating;91%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 7h; Inert atmosphere;76%
With dicyclohexyl-carbodiimide In tetrahydrofuran for 7h; Reflux;48%
i-Amyl alcohol
123-51-3

i-Amyl alcohol

caffeic acid
331-39-5

caffeic acid

(E)-isopentyl 3-(3,4-dihydroxyphenyl)acrylate

(E)-isopentyl 3-(3,4-dihydroxyphenyl)acrylate

Conditions
ConditionsYield
With sulfuric acid at 142℃; for 0.0833333h; Microwave irradiation;91%
With sulfuric acid under 9308.91 Torr; Microwave irradiation; Inert atmosphere; Sealed tube; Reflux;90%
With ytterbium(III) triflate In nitromethane at 120℃; for 1h;38.1%
pentan-1-ol
71-41-0

pentan-1-ol

caffeic acid
331-39-5

caffeic acid

pentyl (E)-3-(3,4-dihydroxyphenyl)acrylate
136944-11-1

pentyl (E)-3-(3,4-dihydroxyphenyl)acrylate

Conditions
ConditionsYield
With sulfuric acid under 9308.91 Torr; Microwave irradiation; Inert atmosphere; Sealed tube; Reflux;91%
With dicyclohexyl-carbodiimide In 1,4-dioxane at 5℃; for 48h;
With toluene-4-sulfonic acid Reflux;
4-Methylbenzyl alcohol
589-18-4

4-Methylbenzyl alcohol

caffeic acid
331-39-5

caffeic acid

(E)-4-methylbenzyl 3-(3,4-dihydroxyphenyl)acrylate

(E)-4-methylbenzyl 3-(3,4-dihydroxyphenyl)acrylate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃;91%
caffeic acid
331-39-5

caffeic acid

benzyl bromide
100-39-0

benzyl bromide

(E)-benzyl 3-(3,4-bis(benzyloxy)phenyl)acrylate
951288-55-4

(E)-benzyl 3-(3,4-bis(benzyloxy)phenyl)acrylate

Conditions
ConditionsYield
With potassium carbonate In acetone Reflux;90%
With potassium carbonate In acetone for 15h; Reflux; Inert atmosphere;90%
With potassium carbonate In acetone for 12h; Heating;85%
With potassium carbonate In dichloromethane at 20℃; for 20h;80%

331-39-5Relevant articles and documents

Ladroside (=6'-Caffeoyl-mussaenoside), a New Iridoid Glucoside from Veronica officinalis L. (Scrophulariaceae) and the Elucidation of the Absolute Configuration at C(8) of Mussaenoside

Affifi-Yazar, Fatma Ue.,Sticher, Otto,Uesato, Shinichi,Nagajima, Kimiko,Inouye, Hiroyuki

, p. 16 - 24 (1981)

A new iridoid glucoside, named ladroside, together with mussaenoside (1) , has been isolated from Veronica officialis L.The structure of ladroside (4) and the identity of mussaenoside have been established by spectral analysis.Additionally, the absolute configuration at C(8) carrying hydroxyl group has been established by chemical evidence.

A New Glycoside, Kusaginin Isolated from Clerodendron trichotomum

Sakurai, Atsushi,Kato, Takahiko

, p. 1573 - 1574 (1983)

A new glycoside, kusaginin was isolated from Clerodendron trichotomum Thunb. and 2-(3,4-dihydroxyphenyl)ethyl 3-O-α-L-rhamnopyranosyl-4-O-(3,4-dihydroxycinnamoyl)-β-D-glucopyranoside was assigned to this substance from studies on the hydrolysis products and from analyses of the 1H NMR and 13C NMR spectra.

MALONATED FLAVONOL GLYCOSIDES AND 3,5-DICAFFEOYLQUINIC ACID FROM PEARS

Wald, Burkard,Wray, Victor,Galensa, Rudolf,Herrmann, Karl

, p. 663 - 664 (1989)

Key Word Index--Pyrus communis; Rosaceae; pears; malonated flavonol glucosides; 3,5-dicaffeoylquinic acid.Abstract--3-O-(6''-O-malonyl)-β-Glucosides of quercetin, kaempferol, isorhamnetin and 3,5-dicaffeoylquinic acid were isolated and identified from leaves of pears.The compounds are also present in the fruits.

Two new monoterpenes and one dicaffeic acid ester from Sibiraea angustata with hypolipidemic activities in HepG2 cells in Vitro

Li, Bin,Chen, Xiaotian,Wang, Zhangwei,Liu, Hongdong,Liu, Bo,Yu, Shishan,Lai, Xuewen,Xu, Xianghong,Hayashi, Toshimitsu

, p. 319 - 323 (2015)

Two new monoterpenes, named sibiscolacton B (1) and sibiscolacton C (2), together with a sorbate obtained from the natural product 1, 6-sorbitol-O-dicaffeic acid ester (3), were isolated from an aqueous extract of the aerial portion of Sibiraea angustata. The compounds' structures were elucidated on the basis of extensive spectroscopic analysis, as well as literature comparisons. A preliminary in vitro bioassay showed that all of the compounds exhibited hypolipidemic effects in HepG2 cells.

Rhamnetin Glycosides from the Genus Spiraea

Olennikov,Chirikova

, p. 41 - 45 (2018)

Rhamnetin (7-O-methylquercetin,1) and its glycosides were found for the first time in the genus Spiraea (Rosaceae) during chromatographic studies of representatives from the subgenus Protospiraea. Leaves of S. salicifolia yielded1, rhamnetin-3-O-β-D-glucopyranoside (2), and two new flavonoids3and4that were identified by UV, IR, and NMR spectroscopy and mass spectrometry as rhamnetin-3-O-(6″-O-p-coumaroyl)-β-D-glucopyranoside (spiraearhamnin A,3) and rhamnetin-3-O-(6″-O-caffeoyl)-β-D-glucopyranoside (spiraearhamnin B,4). Leaves of S. betulifolia and S. betulifolia var. aemiliana afforded1and2and glycosides of kaempferol, quercetin, and isorhamnetin. Species of the subgenus Metaspiraea (S. alpina, S. chamaedryfolia, S. dahurica, S. hypericifolia, and S. media) did not contain1or its derivatives.

Bioactive constituents from Chinese natural medicines. XXXVI.1) four new acylated phenylethanoid oligoglycosides, kankanosides J1, J2, K1, and K2, from stems of cistanche tubulosa

Pan, Yingni,Morikawa, Toshio,Ninomiya, Kiyofumi,Imura, Katsuya,Yuan, Dan,Yoshikawa, Masayuki,Muraoka, Osamu

, p. 575 - 578 (2010)

Four new acylated phenylethanoid oligoglycosides, kankanosides J 1 (1), J2 (2), K1 (3), and K2 (4), were isolated from stems of Cistanche tubulosa (Orobanchaceae) together with isocampneoside I (5). Their struct

Analysis of protein-phenolic compound modifications using electrochemistry coupled to mass spectrometry

Kallinich, Constanze,Schefer, Simone,Rohn, Sascha

, (2018)

In the last decade, electrochemical oxidation coupled with mass spectrometry has been successfully used for the analysis of metabolic studies. The application focused in this study was to investigate the redox potential of different phenolic compounds such as the very prominent chlorogenic acid. Further, EC/ESI-MS was used as preparation technique for analyzing adduct formation between electrochemically oxidized phenolic compounds and food proteins, e.g., alpha-lactalbumin or peptides derived from a tryptic digestion. In the first step of this approach, two reactant solutions are combined and mixed: one contains the solution of the digested protein, and the other contains the phenolic compound of interest, which was, prior to the mixing process, electrochemically transformed to several oxidation products using a boron-doped diamond working electrode. As a result, a Michael-type addition led to covalent binding of the activated phenolic compounds to reactive protein/peptide side chains. In a follow-up approach, the reaction mix was further separated chromatographically and finally detected using ESI-HRMS. Compound-specific, electrochemical oxidation of phenolic acids was performed successfully, and various oxidation and reaction products with proteins/peptides were observed. Further optimization of the reaction (conditions) is required, as well as structural elucidation concerning the final adducts, which can be phenolic compound oligomers, but even more interestingly, quite complex mixtures of proteins and oxidation products.

New thiophene and flavonoid from tagetes minuta leaves growing in saudi arabia

Al-Musayeib, Nawal M.,Mohamed, Gamal A.,Ibrahim, Sabrin R. M.,Ross, Samir A.

, p. 2819 - 2828 (2014)

Phytochemical investigation of the methanolic extract of Tagetes minuta L. (Asteraceae) leaves resulted in the isolation and identification of two new compounds: 5-methyl-2,2',5',2'',5'',2''',5''',2''''-quinquethiophene (1) and quercetagetin-6-O-(6-Ocaffe

Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata

Luecha, Prathan,Umehara, Kaoru,Miyase, Toshio,Noguchi, Hiroshi

, p. 1954 - 1959 (2009)

Antiestrogenic compounds were investigated from Thai indigenous plants for galactogogues since estrogen is reported to suppress lactation in breastfeeding women. The aerial parts of the Thai medicinal plant Capparis flavicans, which has traditionally been

Cytotoxic triterpenoid saponins from Clematis tangutica

Zhao, Min,Da-Wa, Zhuo-Ma,Guo, Da-Le,Fang, Dong-Mei,Chen, Xiao-Zhen,Xu, Hong-Xi,Gu, Yu-Cheng,Xia, Bing,Chen, Lei,Ding, Li-Sheng,Zhou, Yan

, p. 228 - 237 (2016)

Eight previously undescribed oleanane-type triterpenoid saponins, clematangoticosides A-H, together with eight known saponins, were isolated from the whole plants of Clematis tangutica (Maxim.) Korsh. Their structures were elucidated by extensive spectroscopic analysis, in combination with chemical methods (acid hydrolysis and mild alkaline hydrolysis). Clematangoticosides D-G were found to be unusual 23, 28-bidesmosidic glycosides. The cytotoxic activities of all of the isolated saponins were evaluated against the four human cancer cell lines SGC-7901, HepG2, HL-60 and U251MG. Clematoside S, sapindoside B, kalopanax saponin A, and koelreuteria saponin A exhibited cytotoxicity against all of the test cancer cell lines with IC50 values in the range of 1.88–27.20?μM, while clematangoticoside D and F showed selective cytotoxicity against SGC-7901 with IC50 values of 24.22 and 21.35?μM, respectively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 331-39-5